Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | IDO1 | P14902 | 2/20 | 0.55 |
| ▸ | AGXT | P21549 | 1/20 | 0.52 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL177923 | 0.88 | TSHR (0.67) | TSHRIDO1AGXTCALM1ALDH1A1 | |
| Water SCHEMBL28419682 | 0.85 | TSHR (0.63) | TSHRIDO1AGXTCALM1ALDH1A1 | |
| SCHEMBL4363419 | 0.85 | TSHR (0.63) | TSHRIDO1AGXTCALM1ALDH1A1 | |
| SCHEMBL14500132 | 0.85 | TSHR (0.50) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL10942723 | 0.83 | TSHR (0.48) | TSHRIDO1AGXTSLC6A2SLC6A3 | |
| SCHEMBL3697981 | 0.79 | ALDH1A1 (0.48) | TSHRIDO1ALDH1A1SLC6A2SLC6A3 | |
| SCHEMBL26656 | 0.78 | TSHR (0.55) | TSHRIDO1AGXTCALM1ALDH1A1 | |
| SCHEMBL11513295 | 0.78 | TSHR (0.55) | TSHRIDO1AGXTCALM1ALDH1A1 | |
| SCHEMBL7925639 | 0.78 | TSHR (0.55) | TSHRIDO1AGXTCALM1ALDH1A1 | |
| SCHEMBL7915801 | 0.78 | TSHR (0.55) | TSHRIDO1AGXTCALM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110183654-A | A kind of preparation method of fluorine-containing cyanate ester resin | 扬州天启新材料股份有限公司 | 2019-08-30 | — | — | CN | claimed |
| WO-2025126926-A1 | LIPASE VARIANT | 花王株式会社 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025126927-A1 | LIPASE STABILITY IMPROVEMENT METHOD | 花王株式会社 | 2025-06-19 | — | — | WO | disclosed |
| CN-118613164-A | Enveloped virus inactivating agent | 花王株式会社 | 2024-09-06 | — | — | CN | disclosed |
| WO-2024177042-A1 | LIPASE VARIANT | 花王株式会社 | 2024-08-29 | — | — | WO | disclosed |
| WO-2024177043-A1 | LIPASE VARIANT | 花王株式会社 | 2024-08-29 | — | — | WO | disclosed |
| WO-2023230609-A1 | HETEROCYCLIC PAD4 INHIBITORS | CELGENE CORPORATION (US) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023230612-A1 | HETEROCYCLIC PAD4 INHIBITORS | CELGENE CORPORATION (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20220177397-A1 | PROCESSES FOR PREPARING CALIXARENES | SI GROUP, INC. | 2022-06-09 | — | — | US | disclosed |
| US-11225450-B2 | Processes for preparing calixarenes | SI GROUP, INC. (US) | 2022-01-18 | — | — | US | disclosed |
| WO-2007081540-A2 | TYLOPHORINE ANALOGS AS ANTITUMOR AGENTS | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2007-07-19 | — | — | WO | disclosed |
| CN-1434795-A | Acylated Pseudodipeptides with Functionalized Auxiliary Branches | OM PHARMA (CH) | 2003-08-06 | — | — | CN | disclosed |
| US-6003987-A | Ink set recording apparatus and method using ink set having a dye that becomes insoluble when mixed with another dye | CANON KABUSHIKI KAISHA (JP) | 1999-12-21 | — | — | US | disclosed |
| US-4785012-A | OXAZOLE DERIVATIVES CONTAINING ALCOHOLS OR ESTERS | SYNTEX CORPORATION (US) | 1988-11-15 | — | — | US | disclosed |
| US-4427676-A | Thiomorpholine derivatives | JOHN WYETH & BROTHER LTD. (GB) | 1984-01-24 | — | — | US | disclosed |
| US-4163015-A | ANTIBACTERIAL AGENTS | STERLING DRUG INC. (US) | 1979-07-31 | — | — | US | disclosed |
| US-4138405-A | BACTERICIDES | STERLING DRUG INC. (US) | 1979-02-06 | — | — | US | disclosed |
| US-4048194-A | THROMBOXANE B2, PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1977-09-13 | — | — | US | disclosed |
| US-4020173-A | 4α,6-Dihydroxy-2β-carboxaldehyde-3α-tetrahydropyranacetic acid γ-lactone, 6-alkyl ethers | THE UPJOHN COMPANY (US) | 1977-04-26 | — | — | US | disclosed |
| US-4018804-A | PROSTAGLANDINS AND DERIVATIVES | THE UPJOHN COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225450-B2 | Processes for preparing calixarenes | CALU, CALD1, CALR | TSHR 4680/4885IDO1 2577/4885AGXT 721/4885 |
| US-20220177397-A1 | PROCESSES FOR PREPARING CALIXARENES | CALU, CALD1, CALR | TSHR 4680/4885IDO1 2577/4885AGXT 721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.